homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

March 9, 2022

Tasso

Tasso, a leader in clinical-grade blood collection technology, has been named by Fierce Medtech as one of 2021's Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry. Tasso's signature blood collection products and services are currently in use worldwide for a variety of healthcare, pharma, and research applications. The simple, patient-centric technology enables convenient remote collection of clinical grade blood, eliminating clinic access challenges. The Fierce 15 celebrates the spirit of being “fierce” – championing innovation and creativity, even in the face of intense competition. This is Fierce Medtech's 10th annual Fierce 15 selection. An internationally recognized daily report reaching a network of over 90,000 med tech industry professionals, Fierce Medtech provides subscribers with an analysis of the day's top stories. Every year Fierce Medtech evaluates hundreds of private companies from around the world for its annual Fierce 15 list, which is based on a variety of factors such as the strength of its technology, partnerships, venture backers and a competitive market position. Tasso is an emerging healthcare technology company headquartered in Seattle. Tasso is privately held and funded by grants, investments, and co-development deals with various industry leaders.




Email or user name:
Password:
 
Forgot password? Click here.